150 related articles for article (PubMed ID: 14733735)
1. Innate immunity to herpes simplex virus type 2.
Duerst RJ; Morrison LA
Viral Immunol; 2003; 16(4):475-90. PubMed ID: 14733735
[TBL] [Abstract][Full Text] [Related]
2. Herpes simplex virus type 2 virion host shutoff protein regulates alpha/beta interferon but not adaptive immune responses during primary infection in vivo.
Murphy JA; Duerst RJ; Smith TJ; Morrison LA
J Virol; 2003 Sep; 77(17):9337-45. PubMed ID: 12915549
[TBL] [Abstract][Full Text] [Related]
3. Herpes simplex virus-2 in the genital mucosa: insights into the mucosal host response and vaccine development.
Lee AJ; Ashkar AA
Curr Opin Infect Dis; 2012 Feb; 25(1):92-9. PubMed ID: 22143115
[TBL] [Abstract][Full Text] [Related]
4. Role of mucosal immunity in preventing genital herpes infection.
MasCasullo V; Fam E; Keller MJ; Herold BC
Viral Immunol; 2005; 18(4):595-606. PubMed ID: 16359226
[TBL] [Abstract][Full Text] [Related]
5. Detection of herpes simplex virus type 2 (HSV-2) -specific cell-mediated immune responses in guinea pigs during latent HSV-2 genital infection.
Perry CL; Banasik BN; Gorder SR; Xia J; Auclair S; Bourne N; Milligan GN
J Immunol Methods; 2016 Dec; 439():1-7. PubMed ID: 27659010
[TBL] [Abstract][Full Text] [Related]
6. The role of toll-like receptor ligands/agonists in protection against genital HSV-2 infection.
Gill N; Davies EJ; Ashkar AA
Am J Reprod Immunol; 2008 Jan; 59(1):35-43. PubMed ID: 18154594
[TBL] [Abstract][Full Text] [Related]
7. Mucosal innate and adaptive immune responses against herpes simplex virus type 2 in a humanized mouse model.
Kwant-Mitchell A; Ashkar AA; Rosenthal KL
J Virol; 2009 Oct; 83(20):10664-76. PubMed ID: 19656896
[TBL] [Abstract][Full Text] [Related]
8. The potential of immunostimulatory CpG DNA for inducing immunity against genital herpes: opportunities and challenges.
Harandi AM
J Clin Virol; 2004 Jul; 30(3):207-10. PubMed ID: 15135735
[TBL] [Abstract][Full Text] [Related]
9. Tissue-Resident-Memory CD8
Peng T; Phasouk K; Sodroski CN; Sun S; Hwangbo Y; Layton ED; Jin L; Klock A; Diem K; Magaret AS; Jing L; Laing K; Li A; Huang ML; Mertens M; Johnston C; Jerome KR; Koelle DM; Wald A; Knipe DM; Corey L; Zhu J
Front Immunol; 2021; 12():735643. PubMed ID: 34552595
[TBL] [Abstract][Full Text] [Related]
10. Importance of myeloid differentiation factor 88 in innate and acquired immune protection against genital herpes infection in mice.
Tengvall S; Harandi AM
J Reprod Immunol; 2008 Jun; 78(1):49-57. PubMed ID: 17945349
[TBL] [Abstract][Full Text] [Related]
11. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production.
Gill N; Deacon PM; Lichty B; Mossman KL; Ashkar AA
J Virol; 2006 Oct; 80(20):9943-50. PubMed ID: 17005672
[TBL] [Abstract][Full Text] [Related]
12. Rectal immunization generates protective immunity in the female genital tract against herpes simplex virus type 2 infection: relative importance of myeloid differentiation factor 88.
Tengvall S; O'Hagan D; Harandi AM
Antiviral Res; 2008 Jun; 78(3):202-14. PubMed ID: 18276020
[TBL] [Abstract][Full Text] [Related]
13. Neurokinin 1 receptor signaling affects the local innate immune defense against genital herpes virus infection.
Svensson A; Kaim J; Mallard C; Olsson A; Brodin E; Hökfelt T; Eriksson K
J Immunol; 2005 Nov; 175(10):6802-11. PubMed ID: 16272337
[TBL] [Abstract][Full Text] [Related]
14. Innate and adaptive immunity against herpes simplex virus type 2 in the genital mucosa.
Chan T; Barra NG; Lee AJ; Ashkar AA
J Reprod Immunol; 2011 Mar; 88(2):210-8. PubMed ID: 21334750
[TBL] [Abstract][Full Text] [Related]
15. Animal models of herpes simplex virus immunity and pathogenesis.
Kollias CM; Huneke RB; Wigdahl B; Jennings SR
J Neurovirol; 2015 Feb; 21(1):8-23. PubMed ID: 25388226
[TBL] [Abstract][Full Text] [Related]
16. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2.
Parr MB; Kepple L; McDermott MR; Drew MD; Bozzola JJ; Parr EL
Lab Invest; 1994 Mar; 70(3):369-80. PubMed ID: 8145530
[TBL] [Abstract][Full Text] [Related]
17. OASL1 deficiency promotes antiviral protection against genital herpes simplex virus type 2 infection by enhancing type I interferon production.
Oh JE; Lee MS; Kim YJ; Lee HK
Sci Rep; 2016 Jan; 6():19089. PubMed ID: 26750802
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-12 (IL-12) and IL-18 are important in innate defense against genital herpes simplex virus type 2 infection in mice but are not required for the development of acquired gamma interferon-mediated protective immunity.
Harandi AM; Svennerholm B; Holmgren J; Eriksson K
J Virol; 2001 Jul; 75(14):6705-9. PubMed ID: 11413339
[TBL] [Abstract][Full Text] [Related]
19. Nasal and skin delivery of IC31(®)-adjuvanted recombinant HSV-2 gD protein confers protection against genital herpes.
Wizel B; Persson J; Thörn K; Nagy E; Harandi AM
Vaccine; 2012 Jun; 30(29):4361-8. PubMed ID: 22682292
[TBL] [Abstract][Full Text] [Related]
20. NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection.
Gill N; Rosenthal KL; Ashkar AA
J Virol; 2005 Apr; 79(7):4470-8. PubMed ID: 15767447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
